A lifelong journey: Long-term perspectives on Juvenile Idiopathic Arthritis

Area of Science:

• Rheumatology
• Pediatric Rheumatology
• Adult Rheumatology

Background:

• Juvenile Idiopathic Arthritis (JIA) is a heterogeneous group of chronic childhood inflammatory diseases with variable adult outcomes.
• Transitioning JIA patients from pediatric to adult healthcare systems presents significant challenges.
• Continuity of care is often disrupted during this transition, impacting disease management and patient health.

Purpose of the Study:

• To review the complexities and challenges associated with transitioning Juvenile Idiopathic Arthritis patients.
• To emphasize the impact of inadequate transition on disease activity, treatment adherence, and long-term outcomes.
• To highlight the need for optimized, multifaceted approaches for managing adults with JIA.

Main Methods:

• This study is a review of existing literature on Juvenile Idiopathic Arthritis transition care.
• Analysis of factors influencing disease classification, long-term outcomes, and quality of life in JIA patients.
• Synthesis of current knowledge on treatment strategies and management of comorbidities in adult JIA.

Main Results:

• Inadequate transition from pediatric to adult care results in lost follow-up, treatment cessation, and increased disease activity.
• Disease heterogeneity and evolving phenotypes complicate long-term outcome prediction in JIA.
• Despite treatment advances, many JIA patients face long-term disability and joint damage.

Conclusions:

• Optimizing long-term outcomes for adults with JIA necessitates structured transition processes, personalized treatments, and comorbidity management.
• Further research is crucial for refining predictive models and enhancing disease monitoring tools.
• A comprehensive, lifelong management strategy is essential for improving the quality of life for individuals with JIA.